China Drug Repurposing Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Drug Repurposing industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Allergan

    • Biovista

    • Pfizer

    • NuMedii

    • Astellas Pharma

    • SOM Biotech

    • AbbVie

    • Novartis

    • Roche

    By Type:

    • Intravenously Drug

    • Orally Drug

    By Application:

    • CNS Diseases

    • Oncology

    • Neurodegenerative Diseases

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Drug Repurposing Market Overview 2018-2029

    • 1.1 China Drug Repurposing Industry Development Overview

    • 1.2 China Drug Repurposing Industry Development History

    • 1.3 China Drug Repurposing Industry Market Size (2018-2029)

    • 1.4 China Drug Repurposing Market Analysis by Type from Production Side

      • 1.4.1 China Drug Repurposing Production Volume, Production Value and Growth Rate of Intravenously Drug (2018-2029)

      • 1.4.2 China Drug Repurposing Production Volume, Production Value and Growth Rate of Orally Drug (2018-2029)

    • 1.5 China Drug Repurposing Market Analysis by Application from Consumption End

      • 1.5.1 China Drug Repurposing Sales Volume, Sales Value and Growth Rate of CNS Diseases (2018-2029)

      • 1.5.2 China Drug Repurposing Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

      • 1.5.3 China Drug Repurposing Sales Volume, Sales Value and Growth Rate of Neurodegenerative Diseases (2018-2029)

      • 1.5.4 China Drug Repurposing Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Drug Repurposing Market Analysis by Region

      • 1.6.1 North China Drug Repurposing Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Drug Repurposing Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Drug Repurposing Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Drug Repurposing Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Drug Repurposing Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Drug Repurposing Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Drug Repurposing Market Size and Growth Rate from 2018-2029

    Chapter 2 China Drug Repurposing Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Drug Repurposing Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Drug Repurposing Market Status and Competition Analysis in 2023

      • 2.2.3 China Drug Repurposing Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Drug Repurposing Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Drug Repurposing Industry Development

    Chapter 3 Drug RepurposingIndustry Chain Analysis

    • 3.1 Drug Repurposing Industry Chain

    • 3.2 Drug Repurposing Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Drug Repurposing Market

    • 3.3 Drug Repurposing Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Drug Repurposing Market

    Chapter 4 China Drug Repurposing Market, by Type

    • 4.1 China Drug Repurposing Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Drug Repurposing Total Production Volume and Growth Rate from Production Side

    • 4.5 China Drug Repurposing Production Volume and Growth Rate, by Type

      • 4.5.1 China Drug Repurposing Production Volume and Growth Rate of Intravenously Drug

      • 4.5.2 China Drug Repurposing Production Volume and Growth Rate of Orally Drug

    Chapter 5 China Drug Repurposing Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Drug Repurposing Total Market Size and Growth Rate from Consumption End

    • 5.5 China Drug Repurposing Market Size and Growth Rate, by Application

      • 5.5.1 China Drug Repurposing Market Size and Growth Rate of CNS Diseases

      • 5.5.2 China Drug Repurposing Market Size and Growth Rate of Oncology

      • 5.5.3 China Drug Repurposing Market Size and Growth Rate of Neurodegenerative Diseases

      • 5.5.4 China Drug Repurposing Market Size and Growth Rate of Others

    Chapter 6 China Drug Repurposing Market, by Region

    • 6.1 China Drug Repurposing Production Volume and Production Value, by Region

    • 6.2 China Drug Repurposing Sales Volume and Sales Value, by Region

    Chapter 7 North China Drug Repurposing Market Analysis

    • 7.1 North China Drug Repurposing Market, by Type

    • 7.2 North China Drug Repurposing Market, by Application

    Chapter 8 Central China Drug Repurposing Market Analysis

    • 8.1 Central China Drug Repurposing Market, by Type

    • 8.2 Central China Drug Repurposing Market, by Application

    Chapter 9 South China Drug Repurposing Market Analysis

    • 9.1 South China Drug Repurposing Market, by Type

    • 9.2 South China Drug Repurposing Market, by Application

    Chapter 10 East China Drug Repurposing Market Analysis

    • 10.1 East China Drug Repurposing Market, by Type

    • 10.2 East China Drug Repurposing Market, by Application

    Chapter 11 Northeast China Drug Repurposing Market Analysis

    • 11.1 Northeast China Drug Repurposing Market, by Type

    • 11.2 Northeast China Drug Repurposing Market, by Application

    Chapter 12 Southwest China Drug Repurposing Market Analysis

    • 12.1 Southwest China Drug Repurposing Market, by Type

    • 12.2 Southwest China Drug Repurposing Market, by Application

    Chapter 13 Northwest China Drug Repurposing Market Analysis

    • 13.1 Northwest China Drug Repurposing Market, by Type

    • 13.2 Northwest China Drug Repurposing Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Allergan

        • 14.1.1 Allergan Company Profile

        • 14.1.2 Allergan Drug Repurposing Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Biovista

        • 14.2.1 Biovista Company Profile

        • 14.2.2 Biovista Drug Repurposing Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Pfizer

        • 14.3.1 Pfizer Company Profile

        • 14.3.2 Pfizer Drug Repurposing Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 NuMedii

        • 14.4.1 NuMedii Company Profile

        • 14.4.2 NuMedii Drug Repurposing Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Astellas Pharma

        • 14.5.1 Astellas Pharma Company Profile

        • 14.5.2 Astellas Pharma Drug Repurposing Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 SOM Biotech

        • 14.6.1 SOM Biotech Company Profile

        • 14.6.2 SOM Biotech Drug Repurposing Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 AbbVie

        • 14.7.1 AbbVie Company Profile

        • 14.7.2 AbbVie Drug Repurposing Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Novartis

        • 14.8.1 Novartis Company Profile

        • 14.8.2 Novartis Drug Repurposing Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Roche

        • 14.9.1 Roche Company Profile

        • 14.9.2 Roche Drug Repurposing Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Drug Repurposing Industry Research Conclusions

    • 15.2 Drug Repurposing Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Drug Repurposing Industry Market Size (2018-2029)

    • Figure China Drug Repurposing Production Volume, Production Value and Growth Rate of Intravenously Drug (2018-2029)

    • Figure China Drug Repurposing Production Volume, Production Value and Growth Rate of Orally Drug (2018-2029)

    • Figure China Drug Repurposing Sales Volume, Sales Value and Growth Rate of CNS Diseases (2018-2029)

    • Figure China Drug Repurposing Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure China Drug Repurposing Sales Volume, Sales Value and Growth Rate of Neurodegenerative Diseases (2018-2029)

    • Figure China Drug Repurposing Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Drug Repurposing Market Size and Growth Rate from 2018-2029

    • Figure Central China Drug Repurposing Market Size and Growth Rate from 2018-2029

    • Figure South China Drug Repurposing Market Size and Growth Rate from 2018-2029

    • Figure East China Drug Repurposing Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Drug Repurposing Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Drug Repurposing Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Drug Repurposing Market Size and Growth Rate from 2018-2029

    • Figure Drug Repurposing Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Drug Repurposing Market Share by Type in 2018

    • Figure China Drug Repurposing Market Share by Type in 2023

    • Figure China Drug Repurposing Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Drug Repurposing Production Volume and Growth Rate of Intravenously Drug (2018-2023)

    • Figure China Drug Repurposing Production Volume and Growth Rate of Orally Drug (2018-2023)

    • Figure China Drug Repurposing Market Share by Application in 2018

    • Figure China Drug Repurposing Market Share by Application in 2023

    • Figure China Drug Repurposing Total Market Size and Growth Rate from Consumption End

    • Figure China Drug Repurposing Market Size and Growth Rate of CNS Diseases (2018-2023)

    • Figure China Drug Repurposing Market Size and Growth Rate of Oncology (2018-2023)

    • Figure China Drug Repurposing Market Size and Growth Rate of Neurodegenerative Diseases (2018-2023)

    • Figure China Drug Repurposing Market Size and Growth Rate of Others (2018-2023)

    • Table China Drug Repurposing Production Volume by Region (2018-2023)

    • Table China Drug Repurposing Production Volume Share by Region (2018-2023)

    • Figure China Drug Repurposing Production Volume Share by Region (2018-2023)

    • Table China Drug Repurposing Production Value by Region (2018-2023)

    • Table China Drug Repurposing Production Value Share by Region (2018-2023)

    • Figure China Drug Repurposing Production Value Share by Region (2018-2023)

    • Table China Drug Repurposing Sales Volume by Region (2018-2023)

    • Table China Drug Repurposing Sales Volume Share by Region (2018-2023)

    • Figure China Drug Repurposing Sales Volume Share by Region (2018-2023)

    • Table China Drug Repurposing Sales Value by Region (2018-2023)

    • Table China Drug Repurposing Sales Value Share by Region (2018-2023)

    • Figure China Drug Repurposing Sales Value Share by Region (2018-2023)

    • Table North China Drug Repurposing Production Volume by Type (2018-2023)

    • Table North China Drug Repurposing Production Volume Share by Type (2018-2023)

    • Figure North China Drug Repurposing Production Volume Share by Type (2018-2023)

    • Table North China Drug Repurposing Sales Volume by Application (2018-2023)

    • Table North China Drug Repurposing Sales Volume Share by Application (2018-2023)

    • Figure North China Drug Repurposing Sales Volume Share by Application (2018-2023)

    • Table Central China Drug Repurposing Production Volume by Type (2018-2023)

    • Table Central China Drug Repurposing Production Volume Share by Type (2018-2023)

    • Figure Central China Drug Repurposing Production Volume Share by Type (2018-2023)

    • Table Central China Drug Repurposing Sales Volume by Application (2018-2023)

    • Table Central China Drug Repurposing Sales Volume Share by Application (2018-2023)

    • Figure Central China Drug Repurposing Sales Volume Share by Application (2018-2023)

    • Table South China Drug Repurposing Production Volume by Type (2018-2023)

    • Table South China Drug Repurposing Production Volume Share by Type (2018-2023)

    • Figure South China Drug Repurposing Production Volume Share by Type (2018-2023)

    • Table South China Drug Repurposing Sales Volume by Application (2018-2023)

    • Table South China Drug Repurposing Sales Volume Share by Application (2018-2023)

    • Figure South China Drug Repurposing Sales Volume Share by Application (2018-2023)

    • Table East China Drug Repurposing Production Volume by Type (2018-2023)

    • Table East China Drug Repurposing Production Volume Share by Type (2018-2023)

    • Figure East China Drug Repurposing Production Volume Share by Type (2018-2023)

    • Table East China Drug Repurposing Sales Volume by Application (2018-2023)

    • Table East China Drug Repurposing Sales Volume Share by Application (2018-2023)

    • Figure East China Drug Repurposing Sales Volume Share by Application (2018-2023)

    • Table Northeast China Drug Repurposing Production Volume by Type (2018-2023)

    • Table Northeast China Drug Repurposing Production Volume Share by Type (2018-2023)

    • Figure Northeast China Drug Repurposing Production Volume Share by Type (2018-2023)

    • Table Northeast China Drug Repurposing Sales Volume by Application (2018-2023)

    • Table Northeast China Drug Repurposing Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Drug Repurposing Sales Volume Share by Application (2018-2023)

    • Table Southwest China Drug Repurposing Production Volume by Type (2018-2023)

    • Table Southwest China Drug Repurposing Production Volume Share by Type (2018-2023)

    • Figure Southwest China Drug Repurposing Production Volume Share by Type (2018-2023)

    • Table Southwest China Drug Repurposing Sales Volume by Application (2018-2023)

    • Table Southwest China Drug Repurposing Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Drug Repurposing Sales Volume Share by Application (2018-2023)

    • Table Northwest China Drug Repurposing Production Volume by Type (2018-2023)

    • Table Northwest China Drug Repurposing Production Volume Share by Type (2018-2023)

    • Figure Northwest China Drug Repurposing Production Volume Share by Type (2018-2023)

    • Table Northwest China Drug Repurposing Sales Volume by Application (2018-2023)

    • Table Northwest China Drug Repurposing Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Drug Repurposing Sales Volume Share by Application (2018-2023)

    • Table Allergan Company Profile

    • Table Allergan Drug Repurposing Revenue, Price and Gross (2018-2023)

    • Table Biovista Company Profile

    • Table Biovista Drug Repurposing Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Drug Repurposing Revenue, Price and Gross (2018-2023)

    • Table NuMedii Company Profile

    • Table NuMedii Drug Repurposing Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Company Profile

    • Table Astellas Pharma Drug Repurposing Revenue, Price and Gross (2018-2023)

    • Table SOM Biotech Company Profile

    • Table SOM Biotech Drug Repurposing Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Drug Repurposing Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Drug Repurposing Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Drug Repurposing Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.